Block Listing Update

RNS Number : 5750S
Futura Medical PLC
22 November 2011
 



For immediate release

22 November 2011

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Block Listing Update

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that in the six months from the block admission application to AIM on 25 May 2011 for a total of 2,335,000 ordinary shares of 0.2p each in the Company the following changes have taken place:

Futura Medical plc Option Plan

No of Shares in Block Admission

Options Exercised in Period

Block Listing Carried Forward





Unapproved Share Option Scheme

   814,424

(130,269)

684,155

EMI Share Option Scheme

1,520,576

  (49,731)

1,470,845


2,335,000

(180,000)

2,155,000

 

For any further information please contact:

 

Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0) 1483 685 670



mail to: james.barder@futuramedical.com

www.futuramedical.com



Nomura Code Securities Limited


Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200



For media enquiries please contact:




Buchanan


Mark Court / Jessica Fontaine

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISPGGQCGUPGGAP
UK 100

Latest directors dealings